. Author manuscript; available in PMC: 2019 Sep 1.

Published in final edited form as: Pediatr Blood Cancer. 2018 May 11;65(9):e27232. doi: 10.1002/pbc.27232

Table 3.

Multiple regression to investigate the association between OT and POI

		Hazard Ratio (95% CI)	P
Alkylating agent cyclophosphamide equivalent dose, mg/m2	<= 8000	Ref.
	8001-12000	3.3 (0.7, 16.0)	0.1461
	12001-2000	11.2 (3.4, 36.8)	<0.0001
	>20000	36.9 (5.2, 260.5)	0.0003

Ovarian transposition	No	Ref.
Ovarian transposition	Yes	0.6 (0.2, 1.9)	0.4069

Pelvic radiotherapy dose, cGy	≤ 1500	Ref.
Pelvic radiotherapy dose, cGy	>1500	25.2 (3.1, 207.3)	0.0027